Suli Pharma Production
Accelerating, transforming challenge into success
Process design/development; lab, pilot and commercial scale production
Through an exclusive partnership formally established on Jan 1, 2018, AcceleDev – Suli synergistically combined their strengths in the area of pharmaceutical process design, development and production.
Production Site Facilities
- The “Suli Group” founded in 1990, and in Dec 2016 reached the China stock market(# 603585); $300 million annual revenue.
No. 2 Runhua Road, Harbour Economic Development District, Jiangyn, Jiangsu Province, China
- 36000m2 site, located within the Jiangsu Ligang industrial park, China’s #1 Provincial level park.
- Designed and governed according to GMP principles. Also, ISO9001, ISO14001, QHSAS18001 certified.
- EHS system “continuous investment”: $1.35 million in the last 2 years
- Successfully western pharma audited and “RSM approved.”
- Staff of 60 on-site, including 7 experienced process development chemists.
- Production team leader with >20 years of commercial pharma production experience.
- Well-equipped on-site analytical lab
- Total volume reactor capacity: 46,000 L.
- All reactors and processes are monitored / controlled by automated system.
- 12 fume hoods for process development/optimization study work
- Large kilo-lab with multiple walk-in fume hoods and 30-100L vessels complete reactor process development/ production set-ups.
- 30 glass-lined and stainless-steel reactors: 300L to 5000L
- Production scale temp range: -80 to 280 °C
- High pressure up to 5MPa (725psi or 50bar)
- Halar and titanium coated centrifuges and vacuum driers.
- Large scale chromatography on-site
- On-site stability testing: accelerated and long-term on-site stability chambers
